Перейти к содержимому

Diabetes Remission: The Good, The Bad and The Ugly

Endocrinology India

0:00 / 0:00

Diabetes Remission: The Good, The Bad and The Ugly

1 626 просмотров · 1 год назад
Endocrinology India
11,6 тыс. подписчиков
1 626 просмотров · 1 год назад
Diabetes Remission: The Good, The Bad and The Ugly by Dr. Om J Lakhani Diabetes Remission: Truth vs Hype 1. Terminology and Definitions [0:00-5:00] Correct term is "diabetes remission" not "reversal" or "cure" Remission implies need for ongoing support and monitoring Reversal incorrectly suggests no further support needed Cure is inappropriate as diabetes can return Analogy to states of matter and cancer remission Like water changing states, diabetes status can change Similar to cancer remission requiring ongoing monitoring 2. Official Definition (ADA 2021 Consensus) [5:00-10:00] Three key criteria: HbA1c less than 6.5% Maintenance for at least 3 months No glucose-lowering medications Important note: Even medications like SGLT2 inhibitors prescribed for heart failure disqualify remission status 3. Types of Diabetes and Remission Potential [10:00-15:00] Can Undergo Natural Remission: Drug-induced diabetes Gestational diabetes Hospital/stress hyperglycemia Can Achieve Remission with Intervention: Type 2 diabetes (early stages) Endocrine disorder-related diabetes After treating underlying condition Some pancreatic diabetes (early forms) Cannot Currently Achieve Remission: Type 1 diabetes (except temporary honeymoon phase) Most pancreatic diabetes Most monogenic diabetes (MODY) 4. Pathophysiology of Remission [15:00-25:00] Balance Theory: Diabetes results from imbalance between: Insulin resistance Insulin production Remission requires restoring this balance Twin Cycle Hypothesis (Roy Taylor): Focuses on two key organs: Liver: Ectopic fat causes central insulin resistance Pancreas: Fat deposits reduce beta cell function Weight loss reduces fat in both organs 5. Strategies for Achieving Remission [25:00-35:00] Primary Strategy: Weight Loss Target: 10-15% body weight loss Methods: Lifestyle measures Meal replacement (DIRECT trial) GLP-1 agonists and other medications Bariatric surgery Alternative Strategy: Early intensive insulin therapy Particularly successful in Asian populations Can lead to remission in 44-51% of cases 6. Key Studies [35:00-45:00] DIRECT Trial: 46% achieved remission at 12 months 36% maintained at 24 months 86% success rate with more than 15kg weight loss NHS DiRECT Program: 37% achieved remission at 12 months 32% of program completers maintained remission Bariatric Surgery (SOS Study): 76% medication-free at 2 years 69% maintained at 5 years 7. The Good, Bad, and Ugly [45:00-End] Good: Motivating for patients Reduces cost burden Focuses on core pathophysiology Bad: Can distract from main goal of preventing complications May lead to inappropriate discontinuation of beneficial medications Ugly: Misleading marketing and false promises Expensive, unproven programs Misrepresentation of remission criteria Key Takeaways: 1. Remission ≠ Reversal or Cure 2. Weight loss is primary proven strategy 3. Early intervention has better outcomes 4. Ongoing monitoring remains essential 5. Focus should remain on preventing complications More Details: 1. Notes (for Doctors): https://www.endocrinology.co.in/notes... 2. Notes (for Patients):https://www.endocrinology.co.in/patie... 3. Mini-App & Tool:   • Diabetes Remission: The Good, The Bad and ...   4. Presentation: https://endocrinologyindia.myinstamoj... (Paid)